News Industry News IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly January 22, 2022
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015